Gofen & Glossberg LLC Eli Lilly & CO Transaction History

Gofen & Glossberg LLC

$3.89 Billion
Q4 2022

A detailed history of Gofen & Glossberg LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Gofen & Glossberg LLC holds 24,176 shares of LLY stock, worth $19.2 Million. This represents 0.23% of its overall portfolio holdings.

Number of Shares

24,176

Previous 23,804 1.56%

Holding current value

$19.2 Million

Previous $7.7 Million 14.91%

% of portfolio

0.23%

Previous 0.22%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Jan 13, 2023	BUY	$321.55 - $374.67 $119,616 - $139,377	372 Added 1.56%	24,176 $8.85 Million
Q3 2022 Oct 13, 2022	BUY	$296.48 - $337.87 $1.04 Million - $1.19 Million	3,511 Added 17.3%	23,804 $7.7 Million
Q2 2022 Jul 14, 2022	SELL	$278.73 - $327.27 $160,827 - $188,834	-577 Reduced 2.76%	20,293 $6.58 Million
Q1 2022 Apr 14, 2022	SELL	$234.69 - $291.66 $129,314 - $160,704	-551 Reduced 2.57%	20,870 $5.98 Million
Q4 2021 Jan 25, 2022	SELL	$224.85 - $279.04 $132,886 - $164,912	-591 Reduced 2.68%	21,421 $5.92 Million
Q3 2021 Oct 13, 2021	SELL	$221.6 - $272.71 $112,129 - $137,991	-506 Reduced 2.25%	22,012 $5.09 Million
Q2 2021 Jul 13, 2021	BUY	$180.55 - $233.54 $17,513 - $22,653	97 Added 0.43%	22,518 $5.17 Million
Q1 2021 Apr 13, 2021	SELL	$164.32 - $212.72 $87,746 - $113,592	-534 Reduced 2.33%	22,421 $4.19 Million
Q4 2020 Jan 15, 2021	SELL	$130.46 - $172.63 $13,437 - $17,780	-103 Reduced 0.45%	22,955 $3.88 Million
Q3 2020 Oct 09, 2020	SELL	$146.22 - $169.13 $40,210 - $46,510	-275 Reduced 1.18%	23,058 $3.41 Million
Q2 2020 Jul 13, 2020	SELL	$136.42 - $164.18 $30,012 - $36,119	-220 Reduced 0.93%	23,333 $3.83 Million
Q1 2020 Apr 14, 2020	SELL	$119.05 - $147.35 $22,500 - $27,849	-189 Reduced 0.8%	23,553 $3.27 Million
Q4 2019 Jan 28, 2020	BUY	$106.92 - $132.43 $88,850 - $110,049	831 Added 3.63%	23,742 $3.12 Million
Q3 2019 Oct 10, 2019	BUY	$106.79 - $116.16 $8,222 - $8,944	77 Added 0.34%	22,911 $2.56 Million
Q2 2019 Jul 12, 2019	SELL	$110.79 - $129.32 $5,207 - $6,078	-47 Reduced 0.21%	22,834 $2.53 Million
Q1 2019 Apr 11, 2019	SELL	$111.31 - $131.02 $152,160 - $179,104	-1,367 Reduced 5.64%	22,881 $2.97 Million
Q4 2018 Jan 15, 2019	SELL	$105.9 - $118.64 $10,378 - $11,626	-98 Reduced 0.4%	24,248 $2.81 Million
Q3 2018 Oct 11, 2018	BUY	$85.86 - $107.31 $142,871 - $178,563	1,664 Added 7.34%	24,346 $2.61 Million
Q2 2018 Jul 11, 2018	SELL	$75.7 - $86.88 $43,906 - $50,390	-580 Reduced 2.49%	22,682 $1.94 Million
Q1 2018 Apr 11, 2018	BUY	$74.21 - $87.6 $5,936 - $7,008	80 Added 0.35%	23,262 $1.8 Million
Q4 2017 Jan 11, 2018	SELL	$81.94 - $87.89 $9,013 - $9,667	-110 Reduced 0.47%	23,182 $1.96 Million
Q3 2017 Nov 16, 2017	BUY	$77.07 - $85.54 $15,413 - $17,108	200 Added 0.87%	23,292 $1.99 Million
Q2 2017 Aug 16, 2017	BUY	N/A	23,092	23,092 $1.9 Million

Others Institutions Holding LLY

# of Institutions

4,011

Shares Held

751M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $755B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Gofen & Glossberg LLC , based on Form 13F filings with the SEC.

News

Stay updated on Gofen & Glossberg LLC with notifications on news.

Account

Gofen & Glossberg LLC Eli Lilly & CO Transaction History